vs

Side-by-side financial comparison of HIVE Digital Technologies Ltd. (HIVE) and TACTILE SYSTEMS TECHNOLOGY INC (TCMD). Click either name above to swap in a different company.

TACTILE SYSTEMS TECHNOLOGY INC is the larger business by last-quarter revenue ($103.6M vs $93.1M, roughly 1.1× HIVE Digital Technologies Ltd.). TACTILE SYSTEMS TECHNOLOGY INC runs the higher net margin — 10.3% vs -98.1%, a 108.3% gap on every dollar of revenue. On growth, HIVE Digital Technologies Ltd. posted the faster year-over-year revenue change (218.6% vs 21.0%). Over the past eight quarters, HIVE Digital Technologies Ltd.'s revenue compounded faster (102.2% CAGR vs 30.2%).

Mastech Digital, Inc. is a digital transformation and information technology (IT) services company headquartered in Pittsburgh, Pennsylvania, providing services to corporations across North America, Middle East, Asian, and Japan.

Dominion Voting Systems Corporation was a North American company that produced and sold electronic voting hardware and software, including voting machines and tabulators, in Canada and the United States.

HIVE vs TCMD — Head-to-Head

Bigger by revenue
TCMD
TCMD
1.1× larger
TCMD
$103.6M
$93.1M
HIVE
Growing faster (revenue YoY)
HIVE
HIVE
+197.5% gap
HIVE
218.6%
21.0%
TCMD
Higher net margin
TCMD
TCMD
108.3% more per $
TCMD
10.3%
-98.1%
HIVE
Faster 2-yr revenue CAGR
HIVE
HIVE
Annualised
HIVE
102.2%
30.2%
TCMD

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
HIVE
HIVE
TCMD
TCMD
Revenue
$93.1M
$103.6M
Net Profit
$-91.3M
$10.6M
Gross Margin
-27.1%
78.2%
Operating Margin
18.1%
Net Margin
-98.1%
10.3%
Revenue YoY
218.6%
21.0%
Net Profit YoY
-234.0%
9.4%
EPS (diluted)
$-0.38
$0.45

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HIVE
HIVE
TCMD
TCMD
Q4 25
$93.1M
$103.6M
Q3 25
$87.3M
$85.8M
Q2 25
$45.6M
$78.9M
Q1 25
$61.3M
Q4 24
$29.2M
$85.6M
Q3 24
$22.6M
$73.1M
Q2 24
$32.2M
$73.2M
Q1 24
$61.1M
Net Profit
HIVE
HIVE
TCMD
TCMD
Q4 25
$-91.3M
$10.6M
Q3 25
$-15.8M
$8.2M
Q2 25
$35.0M
$3.2M
Q1 25
$-3.0M
Q4 24
$68.2M
$9.7M
Q3 24
$80.0K
$5.2M
Q2 24
$-18.3M
$4.3M
Q1 24
$-2.2M
Gross Margin
HIVE
HIVE
TCMD
TCMD
Q4 25
-27.1%
78.2%
Q3 25
4.7%
75.8%
Q2 25
-13.6%
74.5%
Q1 25
74.0%
Q4 24
-43.7%
75.2%
Q3 24
-66.1%
75.0%
Q2 24
-7.4%
73.9%
Q1 24
71.1%
Operating Margin
HIVE
HIVE
TCMD
TCMD
Q4 25
18.1%
Q3 25
12.8%
Q2 25
5.2%
Q1 25
-7.4%
Q4 24
14.6%
Q3 24
9.3%
Q2 24
8.0%
Q1 24
-4.9%
Net Margin
HIVE
HIVE
TCMD
TCMD
Q4 25
-98.1%
10.3%
Q3 25
-18.1%
9.6%
Q2 25
76.8%
4.1%
Q1 25
-4.9%
Q4 24
233.2%
11.4%
Q3 24
0.4%
7.1%
Q2 24
-56.7%
5.9%
Q1 24
-3.6%
EPS (diluted)
HIVE
HIVE
TCMD
TCMD
Q4 25
$-0.38
$0.45
Q3 25
$-0.07
$0.36
Q2 25
$0.18
$0.14
Q1 25
$-0.13
Q4 24
$0.52
$0.40
Q3 24
$0.00
$0.21
Q2 24
$-0.17
$0.18
Q1 24
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HIVE
HIVE
TCMD
TCMD
Cash + ST InvestmentsLiquidity on hand
$83.4M
Total DebtLower is stronger
$0
Stockholders' EquityBook value
$559.3M
$218.9M
Total Assets
$624.0M
$273.9M
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HIVE
HIVE
TCMD
TCMD
Q4 25
$83.4M
Q3 25
$66.0M
Q2 25
$81.5M
Q1 25
$83.6M
Q4 24
$40.5M
$94.4M
Q3 24
$31.7M
$82.1M
Q2 24
$73.6M
Q1 24
$60.7M
Total Debt
HIVE
HIVE
TCMD
TCMD
Q4 25
$0
Q3 25
$0
Q2 25
Q1 25
Q4 24
Q3 24
$27.0M
Q2 24
$27.8M
Q1 24
$28.5M
Stockholders' Equity
HIVE
HIVE
TCMD
TCMD
Q4 25
$559.3M
$218.9M
Q3 25
$624.6M
$204.9M
Q2 25
$560.5M
$194.9M
Q1 25
$205.6M
Q4 24
$430.9M
$216.6M
Q3 24
$275.5M
$207.9M
Q2 24
$268.6M
$200.7M
Q1 24
$193.5M
Total Assets
HIVE
HIVE
TCMD
TCMD
Q4 25
$624.0M
$273.9M
Q3 25
$693.0M
$259.2M
Q2 25
$628.7M
$273.0M
Q1 25
$280.2M
Q4 24
$478.6M
$297.9M
Q3 24
$334.7M
$287.7M
Q2 24
$278.8M
Q1 24
$272.0M
Debt / Equity
HIVE
HIVE
TCMD
TCMD
Q4 25
0.00×
Q3 25
0.00×
Q2 25
Q1 25
Q4 24
Q3 24
0.13×
Q2 24
0.14×
Q1 24
0.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HIVE
HIVE
TCMD
TCMD
Operating Cash FlowLast quarter
$46.0M
$17.3M
Free Cash FlowOCF − Capex
$16.8M
FCF MarginFCF / Revenue
16.2%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
1.63×
TTM Free Cash FlowTrailing 4 quarters
$40.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HIVE
HIVE
TCMD
TCMD
Q4 25
$46.0M
$17.3M
Q3 25
$-10.6M
$10.3M
Q2 25
$10.2M
$14.8M
Q1 25
$417.0K
Q4 24
$-28.5M
$16.3M
Q3 24
$-2.2M
$10.3M
Q2 24
$-4.4M
$13.1M
Q1 24
$924.0K
Free Cash Flow
HIVE
HIVE
TCMD
TCMD
Q4 25
$16.8M
Q3 25
$9.2M
Q2 25
$14.4M
Q1 25
$38.0K
Q4 24
$-55.5M
$15.9M
Q3 24
$-34.7M
$9.3M
Q2 24
$12.6M
Q1 24
$442.0K
FCF Margin
HIVE
HIVE
TCMD
TCMD
Q4 25
16.2%
Q3 25
10.8%
Q2 25
18.2%
Q1 25
0.1%
Q4 24
-189.9%
18.5%
Q3 24
-153.4%
12.7%
Q2 24
17.3%
Q1 24
0.7%
Capex Intensity
HIVE
HIVE
TCMD
TCMD
Q4 25
0.5%
Q3 25
1.3%
Q2 25
0.5%
Q1 25
0.6%
Q4 24
92.5%
0.5%
Q3 24
143.9%
1.3%
Q2 24
0.7%
Q1 24
0.8%
Cash Conversion
HIVE
HIVE
TCMD
TCMD
Q4 25
1.63×
Q3 25
1.26×
Q2 25
0.29×
4.59×
Q1 25
Q4 24
-0.42×
1.68×
Q3 24
-26.94×
1.99×
Q2 24
3.06×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HIVE
HIVE

Segment breakdown not available.

TCMD
TCMD

Private Insurers$57.6M56%
Medicare$24.6M24%
Durable Medical Equipment Distributors$14.1M14%
Veterans Administration$7.3M7%

Related Comparisons